Key facts
- This page summarizes ORBIMED ADVISORS LLC's Form 4 filing for Acutus Medical, Inc. (AFIB).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 21 Jul 2021, 17:30.
ORBIMED ADVISORS LLC - 19 Jul 2021 Form 4 Insider Report for Acutus Medical, Inc. (AFIB)
- Reporting relationship
- Director, 10%+ Owner
- Issuer ticker
- AFIB
- Reported as of
- 19 Jul 2021
- Net transaction value
- +$14,999,992
- SEC form
- 4
- Accepted by SEC
- 21 Jul 2021, 17:30:13 UTC
- Prior SEC filing
- 23 Jul 2021
- Next SEC filing
- 17 Aug 2021
- Source filing
- View source filing
- Reporting owner signature
- OrbiMed Advisors LLC, By: /s/ Douglas Coon, Chief Compliance Officer
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
ORBIMED ADVISORS LLC filed Form 4 for Acutus Medical, Inc. (AFIB) on 21 Jul 2021.
Change
- Previous filing in this sequence was filed on 23 Jul 2021.
- Current net transaction value: +$14,999,992.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AFIB
transaction
Common Stock
Purchase
- Transaction value
- $9,999,990
- Shares
- +714,285
- Change %
- +17%
- Price
- $14.00*
- Shares after
- 4,872,025
- Date
- 19 Jul 2021
- Ownership
- See Footnotes
- Footnotes
- F1, F2, F4
AFIB
transaction
Common Stock
Purchase
- Transaction value
- $5,000,002
- Shares
- +357,143
- Change %
- +27%
- Price
- $14.00*
- Shares after
- 1,677,361
- Date
- 19 Jul 2021
- Ownership
- See Footnotes
- Footnotes
- F1, F3, F4
AFIB
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,022
- Date
- 19 Jul 2021
- Ownership
- See Footnotes
- Footnotes
- F4, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
These shares of the Issuer's common stock were purchased in the Issuer's underwritten public offering.
Footnote F2
These shares of the Issuer's common stock are held of record by OrbiMed Private Investments IV, LP ("OPI IV"). OrbiMed Capital GP IV LLC ("GP IV") is the general partner of OPI IV, and OrbiMed Advisors LLC ("OrbiMed Advisors"), a registered investment adviser under the Investment Advisors Act of 1940, as amended, is the managing member of GP IV. OrbiMed Advisors and GP IV exercise investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the Shares held by OPI IV.
Footnote F3
These shares of the Issuer's common stock are held of record by OrbiMed Royalty Opportunities II, LP ("ORO II"). OrbiMed ROF II LLC ("ROF II") is the general partner of ORO II, and OrbiMed Advisors is the managing member of ORO II. OrbiMed Advisors and ROF II exercise investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the Shares held by ORO II.
Footnote F4
This report on Form 4 is jointly filed by GP IV, ROF II, and OrbiMed Advisors. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. OrbiMed Advisors and GP IV have designated David Bonita ("Bonita"), a member of OrbiMed Advisors, to serve on the Issuer's board of directors. This report shall not be deemed an admission that any of the Reporting Persons, or Bonita, is a beneficial owner of such securities for the purposes of Section 16 of the Exchange Act, or for any other purposes.
Footnote F5
Represents shares of the Issuer's common stock received by Bonita for service on the Issuer's board of directors. Pursuant to an agreement with OrbiMed Advisors and GP IV, Bonita is obligated to transfer these securities, or the economic benefit thereof, to OrbiMed Advisors and GP IV, which will in turn ensure that such securities or economic benefits are provided to OPI IV.